Switch theme
Sign up to access all valuation multiples
Ryman Healthcare Ltd develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.
1984
n/a
LTM Revenue $520M
LTM EBITDA $104M
$2.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ryman Healthcare has a last 12-month revenue of $520M and a last 12-month EBITDA of $104M.
In the most recent fiscal year, Ryman Healthcare achieved revenue of $372M and an EBITDA of -$29.0M.
Ryman Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ryman Healthcare valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $320M | $372M | XXX | XXX | XXX |
| Gross Profit | $288M | $320M | XXX | XXX | XXX |
| Gross Margin | 90% | 86% | XXX | XXX | XXX |
| EBITDA | $262M | -$29.0M | XXX | XXX | XXX |
| EBITDA Margin | 82% | -8% | XXX | XXX | XXX |
| Net Profit | $396M | $147M | XXX | XXX | XXX |
| Net Margin | 124% | 40% | XXX | XXX | XXX |
| Net Debt | $1.5B | $1.3B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Ryman Healthcare's stock price is NZD 2 (or $1).
Ryman Healthcare has current market cap of NZD 1.8B (or $1.0B), and EV of NZD 4.4B (or $2.5B).
See Ryman Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.5B | $1.0B | XXX | XXX | XXX | XXX | $0.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Ryman Healthcare has market cap of $1.0B and EV of $2.5B.
Ryman Healthcare's trades at 4.8x LTM EV/Revenue multiple, and 24.3x LTM EBITDA.
Analysts estimate Ryman Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Ryman Healthcare and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.5B | XXX | XXX | XXX |
| EV/Revenue | 5.2x | XXX | XXX | XXX |
| EV/EBITDA | 35.8x | XXX | XXX | XXX |
| P/E | -19.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 44.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpRyman Healthcare's NTM/LTM revenue growth is 6%
Ryman Healthcare's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Ryman Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Ryman Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Ryman Healthcare and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -111% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 21% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 64% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 111% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ryman Healthcare acquired XXX companies to date.
Last acquisition by Ryman Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Ryman Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Ryman Healthcare founded? | Ryman Healthcare was founded in 1984. |
| Where is Ryman Healthcare headquartered? | Ryman Healthcare is headquartered in New Zealand. |
| Is Ryman Healthcare publicy listed? | Yes, Ryman Healthcare is a public company listed on NZE. |
| What is the stock symbol of Ryman Healthcare? | Ryman Healthcare trades under RYM ticker. |
| When did Ryman Healthcare go public? | Ryman Healthcare went public in 1999. |
| Who are competitors of Ryman Healthcare? | Similar companies to Ryman Healthcare include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Ryman Healthcare? | Ryman Healthcare's current market cap is $1.0B |
| What is the current revenue of Ryman Healthcare? | Ryman Healthcare's last 12-month revenue is $520M. |
| What is the current EBITDA of Ryman Healthcare? | Ryman Healthcare's last 12-month EBITDA is $104M. |
| What is the current EV/Revenue multiple of Ryman Healthcare? | Current revenue multiple of Ryman Healthcare is 4.8x. |
| What is the current EV/EBITDA multiple of Ryman Healthcare? | Current EBITDA multiple of Ryman Healthcare is 24.3x. |
| What is the current revenue growth of Ryman Healthcare? | Ryman Healthcare revenue growth between 2023 and 2024 was 16%. |
| Is Ryman Healthcare profitable? | Yes, Ryman Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
